SEARCH:   Advanced

This Article Abstract Services Email this article to a friend Alert me to new issues of the journal Rights and Permissions Citing Articles Citing Articles via CrossRef Immunomodulatory effect of 5-azacytidine (5-azaC): potential role in the transplantation setting Blood Sanchez-Abarca et al. 10.1182/blood-2009-03-210393 Supplemental materials for: Sánchez-Abarca et al Files in this Data Supplement: Figure S1. DNMT1 expression decreased along the culture in the presence of 5-azaC from a median (range) of −1.27 (−0.98 to −1.55) after 12 hours to a median (range) of −2.83 (−1.85 to −3.54) after 108 hours (JPG, 37.3 KB) - Figure S2 (JPG, 303 KB) - (A) (1) Whole signature of 7149 filtered genes disregulated in treated versus non-treated cells at 2 (a) and 4 (b) days and (2) signature of 170 genes with a null full discovery rate, represented through hierarchical clustering analysis. (2) Signature of 2189 differentially expressed genes with a FDR of 0,63% among treated versus non-treated cells at 2 (a) and 4 (b) days. (B) Partial gene regulatory network with genes involved in inmune response (blue semicircle) and cell cycle (yellow semicircle) comprising those described on Tables 1 and 2. Green to red background in selected genes maps to fold change at 4 days ranging from −4.72 to 6.04 respectively. Node label displays the gene symbol at NCBI GeneBank, and edge label represents the interaction support on APID database. Figure S3. Dot-plot showing the fluorencence intensity for CD45 among T cells (CD3+) (JPG, 94.4 KB) - This Article Abstract Services Email this article to a friend Alert me to new issues of the journal Rights and Permissions Citing Articles Citing Articles via CrossRef

	Copyright © 2009 by American Society of Hematology         Online ISSN: 1528-0020